Kłusek, M., Chawrylak, K., Kuszneruk, J., Kubas, M. and Krzemińska, K. (2024) “Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review”, Quality in Sport, 18, p. 53252. doi: 10.12775/QS.2024.18.53252.